logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produswest2
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produswest2
Availability, accessibility and use of antivenom for snakebite envenomation in Africa with proposed strategies to overcome the limitations | Journal Article / Commentary | MSF Science Portal
Journal Article
|Commentary

Availability, accessibility and use of antivenom for snakebite envenomation in Africa with proposed strategies to overcome the limitations

Dalhat MM, Potet J, Mohammed A, Chotun N, Tesfahunei HA, Habib AG
Download

Similar Content
Loading...
Loading...
Loading...
Abstract
Africa remains one of the regions with the highest incident and burden of snakebite. The goal of the World Health Organization to halve the global burden of snakebite by 2030 can only be achieved if sub-optimal access to antivenoms in the most affected regions is addressed. We identified upstream, midstream, and downstream factors along the antivenom value chain that prevent access to antivenoms in the African region. We identified windows of opportunities that could be utilized to ensure availability, accessibility, and affordability for snakebite endemic populations in Africa. These include implementation of multicomponent strategies such as intensified advocacy, community engagement, healthcare worker trainings, and leveraging the institutional and governance structure provided by African governments to address the challenges identified.

Subject Area

neglected tropical diseasessnakebite

Collections

World NTD DaySnake envenoming: a neglected crisis

Languages

English
DOI
10.1016/j.toxcx.2023.100152
Published Date
26 Feb 2023
PubMed ID
36936749
Journal
Toxicon: X
Volume | Issue | Pages
Volume 18, Pages 100152
Dimensions Badge